2025-SCOPUS vs Medline - 17 Downloads

The quest for common global standards for the quality assurance of academic journals of Medicine and Healthcare. An audit of linkage  of the MEDLINE and Scopus journal evaluation systems.

A Preprint for publication on the University of Southampton ePrints Server

14th February 2025

David A Rew (DAR)
Consultant Surgeon, Southampton Hospitals
Subject Chair for Medicine,
Scopus Content Selection and Advisory Board (Elsevier BV)

Michael Lehman (ML)
Professor and Director
Brain Health Research Institute
Kent State University, Ohio
Subject Chair for Pharmacology, Toxicology and Pharmaceutics;
Biochemistry, Genetics, Molecular Biology and Neuroscience,
Scopus Content Selection and Advisory Board  (Elsevier BV)

Key Words. Scopus, MEDLINE, quality assurance, comparative analysis

Abstract

Introduction: Academic journals are the bedrock of professional knowledge. The trustworthiness of journal content is critical to safe healthcare practice. Globally branded on line information resources seek to provide quality-assurance to the academic literature. MEDLINE and Scopus are two such resources. They use different expert evaluation processes to select journals for inclusion in their validated data sets. We wished to compare the outputs of title selection processes and of journal holdings in the relevant subject fields by each system.

Methods: Scopus receives a regular feed of titles from MEDLINE which are not further evaluated.  Scopus listed some 5200 Medline-derived journals in mid 2022. 114 journals were found in the MEDLINE collection which had not yet been incorporated in the Scopus Core Collection. These were used as our test sample. Each was reviewed according to standard Scopus title selection criteria by two Scopus healthcare-affiliated Subject Chairs by review of the journal website, metrics and content.

Results: 75 of the 114 journals were deemed to meet all Scopus acceptance criteria without the need for further processing.  34 journals were recommended for acceptance after  formal review through the Scopus Title Evaluation Platform (STEP). Three journals had ceased publication and insufficient information was available on two journals to permit an early decision. At follow up review in January 2025, all newly recommended journals from Medline had been accepted in SCOPUS, excepting eight journals which had demonstrably ceased publication by January 2025.

Conclusions: We were reassured by the broadly congruent conclusions on journal quality from two distinct advisory boards and selection systems using their own journal quality assessment systems. Perfect alignment between two separate reference systems may be unattainable in a very dynamic publishing environment, in which titles are also traded, modified, cease publication, or otherwise become untrackable. Our study also identified a number of issues around journal classification for further consideration.